Skip to content
  • Home
  • 書包: 0 items (滿)
    • English
    • 日本語
    • 中文(简体)
    • 中文(繁體)
    • اللغة العربية
  • About
高級檢索
  • P618: LONG-TERM SAFETY WITH ≥1...
  • 引用
  • 發送短信
  • 打印
  • 導出紀錄
    • 導出到 RefWorks
    • 導出到 EndNoteWeb
    • 導出到 EndNote
  • 添加到書包 從書包裡刪除
  • Permanent link

P618: LONG-TERM SAFETY WITH ≥12 MONTHS OF PIRTOBRUTINIB IN RELAPSED/REFRACTORY (R/R) B-CELL MALIGNANCIES

書目詳細資料
發表在:HemaSphere
Main Authors: Wojciech Jurczak, Catherine C. Coombs, Nirav N. Shah, Jennifer Woyach, Chan Y. Cheah, Krish Patel, Kami Maddocks, Yucai Wang, Catherine E. Muehlenbein, Chunxiao Wang, Sarang Abhyankar, Donald E. Tsai, Toby A. Eyre
格式: Article
語言:英语
出版: Wiley 2023-08-01
在線閱讀:http://journals.lww.com/10.1097/01.HS9.0000969376.62062.53
  • 持有資料
  • 實物特徵
  • 相似書籍
  • 職員瀏覽

因特網

http://journals.lww.com/10.1097/01.HS9.0000969376.62062.53

相似書籍

  • P1087: PIRTOBRUTINIB IN COVALENT BTK-INHIBITOR PRE-TREATED MANTLE CELL LYMPHOMA: UPDATED RESULTS AND SUBGROUP ANALYSIS FROM THE PHASE 1/2 BRUIN STUDY WITH >3 YEARS FOLLOW-UP FROM START OF ENROLLMENT
    由: Wojciech Jurczak, et al.
    出版: (2023-08-01)
  • The potential of pirtobrutinib in multiple B-cell malignancies
    由: Jeffrey L. Jensen, et al.
    出版: (2022-06-01)
  • GENOMIC EVOLUTION AND RESISTANCE TO PIRTOBRUTINIB IN COVALENT BTK-INHIBITOR PRE-TREATED CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: RESULTS FROM THE PHASE I/II BRUIN STUDY
    由: JR Brown, et al.
    出版: (2023-10-01)
  • P1112: PATIENT-REPORTED OUTCOMES (PRO) AMONG PATIENTS WITH MANTLE CELL LYMPHOMA RECEIVING PIRTOBRUTINIB AFTER PRIOR COVALENT BTKI: INTERIM PRO ANALYSIS FROM THE BRUIN PHASE 1/2 STUDY
    由: Jonathon Cohen, et al.
    出版: (2023-08-01)
  • S146: GENOMIC EVOLUTION AND RESISTANCE TO PIRTOBRUTINIB IN COVALENT BTK-INHIBITOR (CBTKI) PRE-TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: RESULTS FROM THE PHASE I/II BRUIN STUDY
    由: Jennifer R. Brown, et al.
    出版: (2023-08-01)

檢索選項

  • 檢索歷史
  • 高級檢索

查找更多

  • 瀏覽目錄
  • 按字母順序瀏覽
  • Explore Channels
  • 課程儲備
  • 新項目

需要幫助?

  • 檢索技巧
  • 咨詢台
  • 常見問題